文献速递眼底病与葡萄膜炎

美国玻璃体视网膜手术的麻醉技术:多中心围手术期结局研究联盟报告

Anesthesia Techniques for Vitreoretinal Surgery in the United States: A Report from the Multicenter Perioperative Outcomes Group Research Consortium.
PubMed 文献 · Am J Ophthalmol · 2024-06-12

基于多中心围手术期结局研究联盟(MPOG)107,066例成人玻璃体视网膜手术的回顾性多中心队列研究显示,67.45%的病例采用监测麻醉监护(MAC),73.63%的机构对超过半数病例实施MAC。MAC使用的变异中47.76%归因于机构差异。慢性肺病、肝病或药物滥用史患者较少接受MAC,而酒精滥用障碍、伴并发症的糖尿病及ASA 4级患者更可能使用MAC;复杂玻璃体切除术、巩膜扣带术及年轻患者更倾向全身麻醉(GA)。

要点

  • 约三分之二的玻璃体视网膜手术在MAC下完成,但巩膜扣带术、复杂玻璃体切除术及年轻患者仍偏好GA。
  • MAC使用存在显著机构间差异,47.76%的变异归因于机构。
  • 慢性肺病、肝病或药物滥用史患者较少接受MAC,而酒精滥用障碍、伴并发症糖尿病及ASA 4级患者更可能使用MAC。

核心结论

  • 约三分之二的玻璃体视网膜手术麻醉为MAC,但巩膜扣带术、复杂玻璃体切除术和年轻患者仍偏好GA。
  • MAC使用在实践中存在较大的机构间差异。

研究设计与样本

  • 回顾性、多中心队列研究,查询MPOG数据库中107,066例接受玻璃体视网膜手术的患者。
  • 纳入2015年1月1日至2021年12月31日期间年龄≥18岁、在MAC或GA下接受玻璃体视网膜手术的患者。
  • 收集患者层面、病例层面和机构层面的协变量,采用多变量混合效应模型确定麻醉类型使用的预测因素。

主要发现

  • 67.45%的玻璃体视网膜手术病例接受MAC,73.63%的机构对超过半数病例实施MAC。
  • 随机效应模型显示,MAC使用的变异中47.76%归因于机构。
  • 观察到MAC使用随年龄增加而增加的趋势。
  • 诊断为慢性肺病、肝病或药物滥用史的患者较少可能接受MAC。
  • 酒精滥用障碍、伴并发症的糖尿病及ASA身体状态4级(对比1、2或3级)的患者更可能使用MAC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the patterns of anesthesia use and their determinants during vitreoretinal (VR) surgeries in academic and community hospitals across the US, using data from the Multicenter Perioperative Outcomes Group (MPOG). DESIGN: A retrospective, multicenter, cohort study. METHODS: We queried the MPOG database of 107,066 patients undergoing VR surgeries. Patients (≥18 years) undergoing VR surgery with monitored anesthesia care (MAC) or general anesthesia (GA) from January 1, 2015 to December 31, 2021 were included. Patient-level, case-based, and institutional-level covariates were collected. We performed multivariable mixed-effects models to determine predictors of anesthesia type use. The primary outcome was the type of anesthesia (MAC or GA) used during VR surgeries. As a secondary outcome, MAC cases were further classified based on the additional use of sedation into MAC with or without sedation. RESULTS: We found that 67.45% of VR surgery cases received MAC, and 73.63% of institutions administered MAC to more than half of cases. Random effect modeling revealed that 47.76% of the variation in MAC use was attributed to institutions. A trend toward increased use of MAC with increasing age was observed. Patients diagnosed with chronic pulmonary disease, liver disease, or a history of drug abuse were less likely to receive MAC. Conversely, we found that patients with reported alcohol abuse disorder, diabetes with complications, and those with American Society of Anesthesiologists (ASA) physical status of 4 (vs. 1, 2, or 3) were more likely to use MAC. Compared to non-complex VR surgeries, there was a notably decreased likelihood of MAC use in complex PPV (P = .004), PPV + scleral buckle (SB) for retinal detachment (P < .0001), and primary SB surgery (P < .0001). CONCLUSIONS: Approximately 2/3 of VR anesthesia is under MAC, but GA is still preferred for SBs, complex vitrectomy, and younger patients. We show that large interinstitutional variation for using MAC in practice exists.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chauhan MZ, Soliman MK, Pace NL, et al. Anesthesia Techniques for Vitreoretinal Surgery in the United States: A Report from the Multicenter Perioperative Outcomes Group Research Consortium. Am J Ophthalmol. 2024. PMID: 38871268. doi:10.1016/j.ajo.2024.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。